Drug Topics

FEBRUARY 25, 2025

Miudella achieves similar efficacy to other available copper IUDs with less than half the dose of copper.

FDA 466

FDA 466

STAT

FEBRUARY 25, 2025

Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells, as the pharma giant seeks to draw patients away from cheap, compounded copies of weight loss medications. Zepbound was originally sold in injectable pens at a list price of about $1,000 per month, but Lilly last year launched the lowest doses of the medication, 2.5 milligrams and 5 milligrams, in vials at $399 and $549 a month.

Compounding 136

Compounding Insurance 136

Drug Topics

FEBRUARY 25, 2025

The increased risk of symptoms only includes respiratory-related symptoms or brain fog.

340

340

STAT

FEBRUARY 25, 2025

After a top UnitedHealth Group executive was gunned down in New York City in December , the company’s risk intelligence team combed the internet for new threats. It didn’t take long to find them. The night of the shooting, a chilling entry appeared at the bottom of another executive’s LinkedIn post: “You’re next.” The following morning, Minnetonka police interviewed that executive at the company’s office in the otherwise sleepy, snow-covered Minne

Insurance 143

Insurance 143

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

FEBRUARY 25, 2025

The results of this study show that the concurrent presence of asthma and obesity did not synergistically amplify inflammation in children with both asthma and overweight/obesity.

281

281

STAT

FEBRUARY 25, 2025

The tiny number of Indigenous students in U.S. medical schools has long been a concern, but Native American medical leaders were taken aback to see 22% fewer American Indian or Alaska Native students had enrolled last year when numbers were released in January. “It’s pathetic, isn’t it? It’s so small,” said Donald Warne, a Lakota physician and co-director of the Center for Indigenous Health at the Johns Hopkins Bloomberg School of Public Health, as he looked cl

Medical Schools 120

Medical Schools 120

STAT

FEBRUARY 25, 2025

Since the end of World War II, the business plan of American universities has included two key principles that now are undergoing rapid disruptive change: Student-athletes participate in college sports in exchange for tuition, room, and board. Federal funding for academic research is the primary engine for the nation’s basic science enterprise.

113

113

Drug Topics

FEBRUARY 25, 2025

Crystal Zhou, PharmD, APh, AHSCP, BCACP, joined Drug Topics to further discuss the Cut Hypertension Program and nontraditional roles within health care.

247

247

The Checkup by Singlecare

FEBRUARY 25, 2025

Linzess (linaclotide) is a brand-name medication that has long been FDA approved to treat chronic constipation from irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). In 2023, the FDA also approved Linzess as the first treatment for pediatric functional constipation, a condition in children and adolescents that causes infrequent bowel movements and hard stools that are difficult to pass.

Dosage 87

Dosage FDA 87

Drug Topics

FEBRUARY 25, 2025

The technology will be available to patients in the United States in March 2025.

FDA 216

FDA 216

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

FEBRUARY 25, 2025

In recent years, an idea has taken hold across the ideological spectrum: The rise in diabetes and obesity in the United States is attributable to addictive, ultra-processed foods that dominate the American diet. But many people who are enthusiastically objecting to ultra-processed foods have little (if any) understanding of what the phrase means.  Legislatures, governors, government agencies, and plaintiff attorneys are taking action against ultra-processed foods, but there is no clear defi

83

83

Fierce Healthcare

FEBRUARY 25, 2025

Republican holdouts, who stated repeatedly they would not vote for the bill, ultimately opted to advance legislation which will require significant Medicaid cuts.

140

140

STAT

FEBRUARY 25, 2025

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning. A bunch of people I know (including me) have gotten sick recently. It’s a particularly intense flu season right now. Hope everyone is taking care of themselves.

89

89

pharmaphorum

FEBRUARY 25, 2025

Ten out of 11 children with congenital deafness treated with a gene therapy developed by Regeneron have seen "notable" improvements in hearing

132

132

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

STAT

FEBRUARY 25, 2025

Rise and shine, everyone, another busy day is on the way. We can tell by the speed at which the notes are arriving through the various communications channels on our laptop and phone, and by the number of motor vehicles passing by our window. As for us, we are trying to slow things down by engaging in the usual ritual of brewing cups of stimulation.

Compounding 80

Compounding FDA Compounding Pharmacies Communication 80

PharmaVoice

FEBRUARY 25, 2025

Cavazzoni stepped down from her role as head of the FDA’s main drug review office in mid-January. She will succeed Aida Habtezion.

FDA 130

FDA 130

European Pharmaceutical Review

FEBRUARY 25, 2025

Scientists have developed a new, potentially safer method to produce ethylene oxide. Based on the proposed technique, adding small amounts of nickel atoms to silver catalysts can maintain production efficiency while eliminating the need for chlorine, leading to a reduced environmental impact for ethylene oxide manufacturing. What sparked this development?

52

52

Fierce Healthcare

FEBRUARY 25, 2025

It was the late 2000s. The Apple iPhone had recently been introduced and on-demand music libraries were becoming popular. | Because demand for mental healthcare is high, experts say, there is a need for innovative tools to help broaden access to music therapy.

115

115

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

PharmaVoice

FEBRUARY 25, 2025

Orphan drug development has long been incentivized by government policy. But as the financial math shifts, so do the risks of bringing rare disease drugs to market.

113

113

Pharmaceutical Technology

FEBRUARY 25, 2025

Samsung Bioepis has now allegedly sub-licensed its Stelara biosimilar rights to a health conglomerate, breaching a previous settlement.

99

99

Pharmacy Times

FEBRUARY 25, 2025

Levonorgestrel-releasing intrauterine devices were not found to increase womens risks of these conditions.

97

97

STAT

FEBRUARY 25, 2025

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Everyone’s talking about egg prices, but what I’m most worried about is my apartment’s heating bill. Apparently I’m not alone.

Insurance 96

Insurance 96

pharmaphorum

FEBRUARY 25, 2025

In a move that will raise eyebrows in Washington, Pfizer has hired former FDA director Patricia Cavazzoni as its new chief medical officer

FDA 95

FDA 95

Pharmacy Times

FEBRUARY 25, 2025

The label changes to buprenorphine extended-release injections can increase convenience and adherence for patients with moderate to severe opioid use disorder.

Labelling 89

Labelling FDA 89

The Checkup by Singlecare

FEBRUARY 25, 2025

Semaglutide, sold under brand names like Ozempic, Rybelsus, and Wegovy, are newer medications treating Type 2 diabetes and obesity. The prescription drug has quickly grown in popularity due to its weight management abilities. In fact, its become so popular that the demand for compounded semaglutide formulas has grown significantly for its lower price (though reports show its not as safe as the name brand and generic options).

Dosage 72

Dosage Scheduling Appointments Compounding FDA 72

Pharmacy Times

FEBRUARY 25, 2025

According to Pranav Garimella, pharmacists are essential in counseling patients with CKD on the appropriate use of semaglutide.

77

77

pharmaphorum

FEBRUARY 25, 2025

Former UK Prime Minister Rishi Sunak has joined Prostate Cancer Research as an ambassador for its campaign for a national screening programme.

72

72

Pharmaceutical Technology

FEBRUARY 25, 2025

Gilead Sciences has announced EMA validation for a parallel accelerated review of lenacapavirs MAA and EU-M4all applications.

69

69

pharmaphorum

FEBRUARY 25, 2025

Researchers developed an artificial intelligence-powered tool that was able to detect two-thirds of epilepsy brain lesions missed by radiologists.

66

66

Fierce Healthcare

FEBRUARY 25, 2025

The three largest pharmacy benefit managers are looking to take their legal back-and-forth with the Federal Trade Commission to the 8th Circuit Court, according to a court filing issued late last week.

65

65

Pharmacy Times

FEBRUARY 25, 2025

The administration of immunotherapy in adjuvant, neoadjuvant, and perioperative settings offers distinct benefits and challenges in resectable cancers, with recent clinical trials highlighting its potential to improve long-term outcomes and the need for further research into biomarkers and combination strategies.

65

65

Pharmaceutical Technology

FEBRUARY 25, 2025

Entrada plans to initiate the Phase Ib study of ENTR-601-44 in the US in the first half of next year.

FDA 64

FDA 64

Pharmacy Times

FEBRUARY 25, 2025

Phil Vigeant shares benefits and considerations of plant-based protein powders, highlighting the pharmacist's role in recommending quality plant-based protein powders.

65

65